Compass Therapeutics, Inc. announced that on February 20, 2023, David Wurzer, a member of the Board of Directors, notified the Company of his resignation from the Board, and all committees thereof, for personal family reasons effective immediately. Mr. Wurzer's resignation was not the result of a disagreement with the Company on any matter relating to the Company's operations, policies or practices.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.31 USD | 0.00% | -7.09% | -16.03% |
05-28 | Compass Therapeutics Appoints Thomas Schuetz as CEO | MT |
05-28 | Compass Therapeutics, Inc. Announces CEO Changes | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.03% | 180M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.31% | 16.5B | |
+2.44% | 13.39B | |
+27.89% | 11.1B |
- Stock Market
- Equities
- CMPX Stock
- News Compass Therapeutics, Inc.
- Compass Therapeutics, Inc. Announces Resignation of David Wurzer to Board of Directors and Committees